Such a possibility emerged in 2005 when it was reported that mice with germline deletion of ß-arrestin 2 (Arrb2-/-) experience enhanced analgesia with attenuated respiratory depression when administered systemic morphine (Raehal et al., 2005). Here, ARRB1 is linked to Respiratory insufficiency due to muscle weakness.